Increasing HIV Prevention Access in Rio de Janeiro
Part of Immune system & allergy, Infections clinical trials.
This study helps people at higher risk of HIV get access to PrEP, a daily medication that prevents HIV infection. The program focuses on underserved communities in Rio de Janeiro and aims to make PrEP easier to access and use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 15 years or older
- You are HIV-negative (confirmed by a screening test)
- You are interested in starting PrEP or getting an HIV test
- You fit into one of the groups the study focuses on: gay or bisexual men, transgender women, sex workers, or women facing financial hardship
- You meet Brazil's national health guidelines for PrEP eligibility
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests online programs to help people who are at higher risk for HIV get prevention or treatment. It aims to see if digital tools can improve access to and use of HIV medications.
This study tests whether a peer-led program helps young people in Brazil start and stay on PrEP, a daily pill that prevents HIV. You would either get support from a trained peer or the usual care, and the goal is to see which works better for preventing HIV.
This study tests an all-in-one HIV prevention package for young men at higher risk of HIV. It combines a new long-acting PrEP (injectable HIV prevention) with mobile health support and sexually transmitted infection prevention. The goal is to see if this comprehensive approach works better than standard care.
This study helps transgender women who are not regularly using PrEP (a daily pill to prevent HIV) get access to HIV prevention services. It uses a smartphone to take pictures and connect with support.
This study tests ways to help Latino men who have sex with men use PrEP, a medicine that helps prevent HIV. You may be invited if you are HIV-negative (or your status is unknown), are not currently on PrEP, and can read and write Spanish.
This study tests a program to help men who use stimulants and are at risk for HIV reduce drug use and prevent HIV infection. Participants may get access to PrEP, a daily pill that prevents HIV, and support to lower their risk.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.